117 results
Page 3 of 6
8-K
EX-99.1
vst69ueg1mv
26 Jul 23
Viking Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:23pm
8-K
EX-99.1
ryjia4aqs95x
26 Apr 23
Viking Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
PRE 14A
r9albhedc56q91
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
4yt36kim 2vcptcd3j
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
424B5
uxwd0bkkq
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
q1i0i7fu0g3 fftrzu8f
29 Mar 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
potdhkm5xe5pi
26 Oct 22
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:32pm
8-K
EX-99.1
lay2jkhyaq45j sbk
27 Jul 22
Viking Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
kff47f1
27 Apr 22
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
ic18ks18 po85
9 Feb 22
Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.1
es9 uj5ftem16
3 Nov 21
Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:10pm